This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to quantify the incidence of any reported adverse event in patients taking macrolide antibiotics compared to placebo for any indication. The adverse events will be handled separately as adverse reactions, adverse effects, serious adverse events or subsequent carriage of resistant bacteria. Our secondary objective is to quantify the overall incidence of any reported adverse events inpatients taking macrolide antibiotics compared to placebo.
|Number of pages||10|
|Journal||Cochrane Database of Systematic Reviews|
|Publication status||Published - 14 Aug 2015|